MDGL Madrigal Pharmaceuticals, Inc.
$534.86
▼ 0.90%
36
Value
14
P/E-50.18
8
P/B28.57
28
P/S10.83
20
EV/EBITDA-41.89
5
Growth
67
Revenue Growth432.1%
100
EPS Growth41.3%
46
FCF Growth58.4%
51
Momentum
77
12-Month Return81.2%
100
3-Month Return15.4%
85
1-Month Return2.9%
59
RSI (14)51.35
53
50/200 MABullish
75
Profitability
20
ROE-50.2%
42
ROA-25.2%
0
Gross Margin93.1%
74
Operating Margin-27.7%
0
Net Margin-27.3%
0
FCF Yield-2.2%
0
Risk
5
Beta-1.04
10
60-Day Volatility46.4%
0
QScore Analysis